Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von GraveDigger 

Hims & Hers Health Inc. diskutieren

Hims & Hers Health Inc.

WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Aktie / ? /

19,46 €
1,51 %

Buy Hims & Hers Health Inc.

Einschätzung Buy
Rendite (%) 12,73 %
Kursziel 14,12
Veränderung
Endet am 28.02.24

Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $15.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 146,73 %
Kursziel 9,99
Veränderung
Endet am 28.07.24

Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at TD Cowen. They set an "outperform" rating and a $11.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 133,56 %
Kursziel 12,78
Veränderung
Endet am 08.08.24

Hims & Hers Health, Inc. (NYSE: HIMS) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $14.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 149,29 %
Kursziel 13,65
Veränderung
Endet am 05.01.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Tigress Financial from $14.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 52,13 %
Kursziel 14,74
Veränderung
Endet am 27.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Citigroup Inc. from $12.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 52,13 %
Kursziel 15,66
Veränderung
Endet am 27.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 57,75 %
Kursziel 14,77
Veränderung
Endet am 28.02.25

Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Imperial Capital from an "in-line" rating to an "outperform" rating. They now have a $16.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 41,51 %
Kursziel 18,55
Veränderung
Endet am 10.04.25

Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Seaport Res Ptn.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) 3,83 %
Kursziel 20,28
Veränderung
Endet am 03.06.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $17.25 to $22.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) -13,09 %
Kursziel 24,19
Veränderung
Endet am 13.06.25

Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $22.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat